You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 20, November 12, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Cancer Antigen 125: Tumor or Serosal Marker in Case of Ascites?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with great interest the case report published in a recent issue of the ARCHIVES.1 Au et al described a 45-year-old woman with severe weight loss and ascites of about 2 months' duration. The abnormal laboratory findings were hypoalbuminemia (16 g/L) and elevated levels of serum cancer antigen 125 (CA-125) (1260 IU/mL) and carbohydrate antigen 19-9 (62.5 IU/mL). Although neither cytological nor microbiological abnormalities were detected in the transudative ascitic fluid, a magnetic resonance imaging scan and a more invasive diagnostic procedure using exploratory laparotomy were performed. No abdominal or pelvic malignancy could be defined to explain the extremely elevated CA-125 levels. The patient was finally diagnosed as having mixed connective tissue disease (MCTD) based on the presence of antinuclear ribonucleoprotein antibody, serositis leading to protein-losing enteropathy, probable Raynaud phenomenon, and the absence of clinical and serological evidence of other autoimmune diseases.

Cancer antigen 125 is a high-molecular-weight glycoprotein . . . [Full Text of this Article]

Corresponding author: Alper Sevinc, MD, Department of Internal Medicine, Inonu University, School of Medicine, Turgut Ozal Medical Center, Malatya, TR-44069, Turkey (e-mail: asevinc@inonu.edu.tr).

Corresponding author: Y. L. Kwong, MD, University Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong (e-mail: ylkwong@hkucc.hku.hk).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA-G Is a Potential Tumor Marker in Malignant Ascites
Singer et al.
Clin. Cancer Res. 2003;9:4460-4464.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.